HealthCare Market Analysis

The global  ballistic composites market  is expected to reach USD 2.18 billion by 2025, according to a new report by Grand View Research, Inc. Unstable geopolitical relations, increasing cross-border tensions have forced nations to strengthen their defense units. Providing lightweight, efficient and advanced combat equipment has been on top priorities of most of the developed as well as developing countries. This has triggered the use of ballistic composites over the past few years. Several factors, like the propensity of the composite armor of supporting the weight of an externally attached component, anchoring composite armor with a platform, safeguarding of ballistic weaknesses at panel joints and corners are taken into consideration while product designing and production are executed. U.S. ballistic composites market revenue, by product, 2014 - 2025 (USD Million) Ballistic vests are envisioned to deflect bullets from several types of guns, while armored vehicles must

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. Vein Illuminator Market, by End-user, 2013 - 2024 (USD Million) The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is fur

The global  acute lymphocytic/lymphoblastic leukemia therapeutics market  is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing public and private initiatives for diagnosis of Acute Lymphoblastic Leukemia (ALL), rising number of bone marrow biopsies, and availability of other treatment options are factors expected to increase the adoption of ALL procedures. For instance, The Baby Friendly Initiative Program by UNICEF (UK) and SickKids-Caribbean Initiative, a collaborative approach between hospitals and healthcare institutions in Canada, aim to provide free diagnosis and treatment services to infants suffering from ALL, who meet certain eligibility criteria. U.S. acute lymphoblastic leukemia therapeutics, by therapy, 2014 - 2025 (USD Million) Furthermore, rising incidence of ALL is anticipated to boost the market. The disease is prevalent among children below 5 years of age. The risk of contracting ALL is the highest

The global  stethoscope market  is expected to reach USD 522.6 million by 2025, according to a new report by Grand View Research, Inc. The global increase in cardiac and pulmonary diseases is likely to drive the market during the forecast period. Furthermore, increase in investments by key companies and government agencies for development and commercialization of various innovative, accurate, and improved frequency, easy-to-use stethoscopes is likely to drive the market. For instance, in October 2015, Rijuven Corporation launched a new FDA-approved device, CardioSleeve, for pediatric use with electrocardiography skills to convert any existing stethoscope into a smart mobile-connected device with digital auscultation, digital analysis, arrhythmia, or murmur, which can identify heart failure. Entry of various electronic stethoscopes in the market is likely to drive the segment at the fastest rate during the forecast period. In August 2015, Eko launched the first Android-connect

The global  healthcare staffing market  is expected to reach USD 43.6 billion by 2025, according to a new report by Grand View Research, Inc. Rising geriatric population has increased the demand for healthcare services around the globe. However, there is a shortage of efficient nurses and other healthcare professionals. Shortage of physicians in the coming years is likely to boost the demand for healthcare staffing market in developed regions over the forecast period. For instance, Association of American Medical Colleges had predicted in 2010 that the U.S. is anticipated to face a shortage of 150,000 doctors over the next 10 to 15 years. Furthermore, availability of skilled professionals at lower costs as and when required is anticipated to propel the market growth in the coming years. Furthermore, in response to the pressure of costs, hospitals are forced to reduce their staff and have implemented policies to ensure that nurses would be available for work when the wor

The global  ophthalmic therapeutics/drugs market  is expected to reach USD 35.7 billion by 2025, according to a new report by Grand View Research, Inc. Increase in funding by public and private bodies for conducting research on ocular disorders with the presence of strong emerging pipeline drugs are some of the factors responsible for the growth of ophthalmic therapeutics market. For instance, the recent approval of Zerviate (cetirizine) for the treatment of allergic conjunctivitis in 2017 and Humira (adalimumab) and Xiidra (lifitegrast) in 2016 as ophthalmic solutions for the treatment of uveitis and dry eyes are expected to boost the market growth. U.S ophthalmic therapeutics/drug market, by class, 2014 - 2025 (USD Billion) Numerous ongoing public-private partnership agreements in the pharmaceutical industry for the development of novel therapeutics are expected to provide this market with lucrative growth opportunities. In the recent years, a number of highly-effective